2405 Wesbrook Mall
Zucara, a spin-off of The Centre for Drug Research and Development (CDRD) and MaRS Innovation (MI), is a company with a novel drug therapy to help prevent hypoglycemia in people with diabetes. It is advancing novel technology that is showing promise as a long-term therapeutic approach to prevent hypoglycemia in people with diabetes who are insulin-dependent.
CEO: Michael Midmer, MSc, MBA
CBO: Jonathon Jafari, MSc, MBA
CSO: Richard Liggins, PhD
Chair, Scientific Advisory Board: Michael Riddell, PhD
Director, Technology & Venture Development: Dominic Jaikaran, PhD, MBA
Please click here for Zucara's technology.